A partially purified outer membrane protein VirB9-1 for low-cost nanovaccines against Anaplasma marginale.


Anaplasma marginale is a devastating tick-borne pathogen causing anaplasmosis in cattle and results in significant economic loss to the cattle industry worldwide. Currently, there is no widely accepted vaccine against A. marginale. New generation subunit vaccines against A. marginale, which are much safer, more efficient and cost-effective, are in great… (More)
DOI: 10.1016/j.vaccine.2016.11.037


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.